Ectoine and hydroxyectoine inhibit aggregation and neurotoxicity of Alzheimer's β-amyloid

FEBS Letters

Volumn 579, Issue 21, 2005, Pages 4775-4780

  Kanapathipillai, Mathumai ^a   Lentzen, Georg ^b   Sierks, Michael ^a   Park, Chan Beum ^a  

^a Arizona State University   (United States)

^b BITOP AG   (Germany)

Author keywords

Amyloid peptide; Alzheimer's disease; Ectoine; Hydroxyectoine; Small molecule chaperones

Indexed keywords

AMYLOID BETA PROTEIN; CHAPERONE; ECTOINE; HYDROXYECTOINE; THIOFLAVINE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; ATOMIC FORCE MICROSCOPY; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG STRUCTURE; FLUORESCENCE; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; NEUROTOXICITY; PRIORITY JOURNAL; PROTEIN AGGREGATION;

AGED; ALZHEIMER DISEASE; AMINO ACIDS, DIAMINO; AMYLOID BETA-PROTEIN; CELL LINE, TUMOR; CELL SURVIVAL; HUMANS; MICROSCOPY, ATOMIC FORCE; MOLECULAR STRUCTURE; NEUROBLASTOMA; PEPTIDE FRAGMENTS;

EID: 24044449002     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2005.07.057     Document Type: Article

References (46)

1. A.J. Modler, K. Gast, G. Lutsch, and G. Damaschun Assembly of amyloid protofibrils via critical oligomers - a novel pathway of amyloid formation J. Mol. Biol. 325 2003 135 148
2. L.C. Serpell Alzheimer's amyloid fibrils: structure and assembly Biochim. Biophys. Acta 1502 2000 16 30
3. M.S. Wolfe Therapeutic strategies for Alzheimer's disease Nat. Rev. Drug. Discov. 1 2002 859 866
4. G. Bitan, M.D. Kirkitadze, A. Lomakin, S.S. Vollers, G.B. Benedek, and D.B. Teplow Amyloid β-protein (Aβ) assembly: Aβ40 and Aβ42 oligomerize through distinct pathways Proc. Natl. Acad. Sci. USA 100 2003 330 335
5. J.W. Kelly The environmental dependency of protein folding best explains prion and amyloid diseases Proc. Natl. Acad. Sci. USA 95 1998 930 932
6. D.R. Booth, M. Sunde, V. Bellotti, C.V. Robinson, S.E. Hutchison, C.C.F. Blake, and M.B. Pepys Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis Nature 385 1997 787 793
7. K. Yutani, S. Tsunasawa, and K. Ogasahara The process of amyloid-like fibril formation by methionine aminipeptidase from a hyperthermophile, Pyrococcus furiosus Biochemistry 39 2000 2769 2777
8. M. Fandrich, M.A. Fletcher, and C.M. Dobson Amyloid fibrils from muscle myoglobin Nature 410 2001 165 166
9. R.M. Murphy Peptide aggregation in neurodegenerative disease Annu. Rev. Biomed. Eng. 4 2002 155 174
10. F.G.D. Felice, J. Houzel, J. Garcia-Abreu, P.R.F. Louzada, R.C. Afonso, M.N.L. Meirelles, R. Lent, V.M. Neto, and S.T. Ferriera Inhibition of Alzheimer's disease β-amyloid aggregation, neurotoxicity, and in vivo deposition by nitrophenols: implications for Alzheimer's therapy FASEB J. 15 2004 1297 1299
11. J.E. Gestwicki, G.R. Crabtree, and I.A. Graef Harnessing chaperones to generate small-molecule inhibitors of amyloid β aggregation Science 306 2004 865 869
12. J. McLaurin, R. Cecal, M.E. Kierstead, X. Tian, A.L. Phinney, M. Manea, J.E. French, M.H.L. Lambermon, A.A. Darabie, M.E. Brown, C. Janus, M.A. Chishti, P. Horne, D. Westaway, P.E. Fraser, H.T.J. Mount, M. Przybylski, and P. St George-Hyslop Therapeutically effective antibodies against amyloid-beta peptide target amyloidbeta residues 4 ∼ 10 and inhibit cytotoxicity and fibrillogenesis Nat. Med. 8 2002 1263 1269
13. R. Liu, B. Yuan, S. Emadi, A. Zameer, P. Schulz, C. McAllister, Y. Lyubchenko, G. Goud, and M. Sierks Single chain variable fragments against β-amyloid (Aβ) can inhibit Aβ aggregation and prevent Aβ-induced neurotoxicity Biochemistry 43 2004 6959 6967
14. J. McLaurin, M. Kierstead, and P. Fraser Anti-beta amyloid aggregation therapy Neurobiol. Aging 23 2002 1580
15. L.O. Tjernberg, J. Naslund, F. Lindqvist, J. Johannsson, A.R. Karlstrom, J. Thyberg, L. Terenius, and C. Nordstedt Arrest of β-amyloid fibril formation by a pentapeptide ligand J. Biol. Chem. 271 1996 8545 8548
16. L.L. Vorob'eva Stressors, stress reactions, and survival of bacteria: a review Appl. Biochem. Microbiol. 40 2004 261 269
17. H. Santos, and M.S. da Costa Organic solutes from thermophiles and hyperthermophiles Methods Enzymol. 334 2001 302 315
18. O.C. Nunes, C.M. Manaia, M.S. Da Costa, and H. Santos Compatible solutes in the themophilic bacteria Rhodothermus marinus and Thermus thermophilus Appl. Environ. Microbiol. 61 1995 2351 2357
19. K. Lippert, and E.A. Galinkski Enzyme stabilization by ectoine-type compatible solutes- protection against heating, freezing and drying Appl. Microbiol. Biotechnol. 37 1992 61 65
20. K. Goller, and E.A. Galinski Protection of a model enzyme (lactate dehydrogenase) against heat, urea and freeze-thaw treatment by compatible solute additive J. Mol. Catal. B: Enzymol. 7 1999 37 45
21. A. Arora, C. Ha, and C.B. Park Inhibition of insulin amyloid formation by small stress molecules FEBS Lett. 564 2004 121 125
22. W.A. Galinski, H.P. Pfeiffer, and H.G. Truper 1,4,5,6-Tetrahydro-2- methyl-4-pyrimidinecarboxylic acid - a novel cyclic amino-acid from halophilic phototrophic bacteria of the genius ectothiorhodospira Eur. J. Biochem. 149 1985 135 139
23. M.M. Anderson, J.D. Breccia, and R. Hatti-Kaul Stabilizing effect of chemical additives against oxidation of lactate dehydrogenase Biotechnol. Appl. Biochem. 32 2000 145 153
24. S. Barth, M. Huhn, B. Matthey, A. Klimka, E.A. Galinski, and A. Engert Compatible-solute-supported periplasmic expression of functional recombinant proteins under stress conditions Appl. Environ. Microbiol. 66 2000 1572 1579
25. N. Borges, A. Ramos, N.D.H. Raven, R.J. Sharp, and H. Santos Comparative study of the thermostabilizing properties of mannosylglycerate and other compatible solutes on model enzymes Extremophiles 6 2002 209 216
26. S. Knapp, R. Ladenstein, and E.A. Galinski Extrinsic protein stabilization by the naturally occuring osmolytes β-hydroxyectoine and betaine Extremophiles 3 1999 191 198
27. M. Manzanera, S. Vilchez, and A. Tunnacliffe High survival and stability rates of Escherichia coli dried in hydroxyectoine FEMS Microbiol. Lett. 233 2004 347 352
28. K.N. Dahlgren Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability J. Biol. Chem. 277 2002 32046 32053
29. H. Levine Thioflavine-T interaction with synthetic Alzheimers-disease beta-amyloid peptides-detection of amyloid aggregation in solution Protein Sci. 2 1993 404 410
30. M.S. Shearman, S.R. Hawtin, and V.J. Tailor The intracellular component of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction is specifically inhibited by beta-amyloid peptides J. Neurochem. 65 1995 218 227
31. W.B. Stine, S.W. Snyder, U.S. Lardor, W.S. Wade, M.F. Miller, T.J. Perun, T.F. Holzman, and G.A. Krafft The nanometer-scale structure of amyloid-beta visualized by atomic force microscopy J. Protein Chem. 15 1996 193 203
32. M.S. Da Costa, H. Santos, and E.A. Galinski An overview of the role and diversity of compatible solutes in Bacteria and Archaea Adv. Biochem. Eng. Biotechnol. 61 1998 117 153
33. E.A. Galinski, and H.G. Trüper Microbial behavior in salt-stressed ecosystems FEMS Microbiol. Rev. 15 1994 95 108
34. E.A. Galinski Osmoadaptation in Bacteria Adv. Microbiol. Physiol. 37 1995 273 328
35. M. Jebbar, R. Talibart, K. Gloux, T. Bernard, and C. Blanco Osmoprotection of Escherichia coli by ectoine: uptake and accumulation characteristics J. Bacteriol. 174 1992 5027 5035
36. D.E. Robertson, and M.F. Roberts Organic osmolytes in methanogenic archaebacteria Biofactors 3 1991 1 9
37. D.J. Selkoe Alzheimer's disease: genes, proteins, and therapy Physiol. Rev. 81 2001 741 766
38. E. Gazit A possible role for π-stacking in the self-assembly of amyloid fibrils FASEB J. 16 2002 77 83
39. J.D. Harper, and P.T. Lansbury Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequence of the time-dependent solubility of amyloid proteins Annu. Rev. Biochem. 66 1997 385 407
40. M. Bouchard, J. Zurdo, E.J. Nettleton, C.M. Dobson, and C.V. Robinson Formation of insulin amyloid fibrils followed by FTIR simultaneously with CD and electron microscopy Protein Sci. 9 2000 1960 1967
41. J. Brange, L. Andersen, E.D. Laursen, G. Meyn, and E. Rasmussen Toward understanding insulin fibrillation J. Pharm. Sci. 86 1997 517 525
42. J. Brange, G.G. Dodson, D.J. Edwards, P.H. Holden, and J.L. Whittingham A model of insulin fibrils derived from the x-ray crystal structure of a monomeric insulin Proteins 27 1997 507 516
43. L. Nielsen, R. Khurana, A. Coats, S. Frokjaer, J. Brange, S. Vyas, V. Uversky, and A.L. Fink Effects of environmental factors on the kinetics of insulin fibril formation: elucidation of the molecular mechanism Biochemistry 40 2001 6036 6046
44. E.P. Melo, T.Q. Faria, L.O. Martins, A.M. Goncalves, and J.M.S. Cabral Cutinase unfolding and stabilization by trehalose and mannosylglycerate Proteins Struct. Funct. Genet. 42 2001 542 552
45. Y. Oberdorfer, S. Schrot, H. Fuchs, E. Gallinski, and A. Janshoff Impact of compatible solutes on the mechanical properties of fibronectin: a single molecule analysis Phys. Chem. Chem. Phys. 5 2003 1876 1881
46. M. Tanaka, Y. Machida, S. Niu, T. Ikeda, N.R. Jana, H. Doi, M. Kurosawa, M. Nekooki, and N. Nukina Trehalose alleviates polyglutamine-mediated in a mouse model of Huntington disease Nat. Med. 10 2004 148 154